Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ELDER PHARMA NATCO PHARMA/
ELDER PHARMA
 
P/E (TTM) x 13.3 -1.0 - View Chart
P/BV x 3.5 0.1 3,465.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 NATCO PHARMA   ELDER PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
ELDER PHARMA
Jun-14
NATCO PHARMA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs847380 222.8%   
Low Rs502188 267.0%   
Sales per share (Unadj.) Rs148.4489.2 30.3%  
Earnings per share (Unadj.) Rs39.2-3.2 -1,232.9%  
Cash flow per share (Unadj.) Rs48.214.4 334.4%  
Dividends per share (Unadj.) Rs5.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs267.1376.5 70.9%  
Shares outstanding (eoy) m182.4720.54 888.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.50.6 783.1%   
Avg P/E ratio x17.2-89.3 -19.3%  
P/CF ratio (eoy) x14.019.7 71.0%  
Price / Book Value ratio x2.50.8 334.8%  
Dividend payout %14.00-   
Avg Mkt Cap Rs m123,0495,832 2,109.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8672,179 223.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07110,048 269.4%  
Other income Rs m1,285257 500.8%   
Total revenues Rs m28,35610,305 275.2%   
Gross profit Rs m9,1172,921 312.1%  
Depreciation Rs m1,638361 453.4%   
Interest Rs m1452,756 5.3%   
Profit before tax Rs m8,61960 14,401.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,466125 1,171.3%   
Profit after tax Rs m7,153-65 -10,952.4%  
Gross profit margin %33.729.1 115.9%  
Effective tax rate %17.0209.1 8.1%   
Net profit margin %26.4-0.6 -4,065.3%  
BALANCE SHEET DATA
Current assets Rs m30,0039,240 324.7%   
Current liabilities Rs m6,8319,998 68.3%   
Net working cap to sales %85.6-7.5 -1,135.1%  
Current ratio x4.40.9 475.2%  
Inventory Days Days63128 49.5%  
Debtors Days Days115602 19.2%  
Net fixed assets Rs m26,57113,642 194.8%   
Share capital Rs m365206 177.5%   
"Free" reserves Rs m48,3737,528 642.6%   
Net worth Rs m48,7387,733 630.2%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m56,57422,882 247.2%  
Interest coverage x60.41.0 5,915.7%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.50.4 109.0%   
Return on assets %12.911.8 109.7%  
Return on equity %14.7-0.8 -1,737.9%  
Return on capital %18.022.3 80.6%  
Exports to sales %03.1 0.0%   
Imports to sales %10.20.4 2,387.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs m2,77243 6,431.6%   
Fx inflow Rs m17,256307 5,628.4%   
Fx outflow Rs m2,772125 2,212.8%   
Net fx Rs m14,484181 7,988.1%   
CASH FLOW
From Operations Rs m8,49111,754 72.2%  
From Investments Rs m-4,771-561 851.2%  
From Financial Activity Rs m-3,630-6,762 53.7%  
Net Cashflow Rs m2085,466 3.8%  

Share Holding

Indian Promoters % 49.7 25.3 196.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 24.0 104.1%  
FIIs % 13.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 74.7 67.4%  
Shareholders   207,571 31,548 658.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Elder Pharma Share Price Performance

Period Natco Pharma Elder Pharma S&P BSE HEALTHCARE
1-Day -2.11% 4.97% 1.18%
1-Month -3.19% 21.21% -0.75%
1-Year 72.80% -64.54% 61.82%
3-Year CAGR 4.96% -51.65% 18.16%
5-Year CAGR 10.96% -37.46% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.